Atlas Trials

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

Clinical trial NCT07710781 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07710781
Sponsor
Ossium Health, Inc.
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hematologic MalignancyAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Biphenotypic LeukemiaAcute Undifferentiated LeukemiaCLL (Chronic Lymphocytic Leukemia)Chronic Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Non Hodgkin LymphomaHodgkin LymphomaCutaneous T Cell Lymphomas (CTCL)
Start date
2026-12-01
Primary completion
2029-03-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.